BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24089457)

  • 21. Association between Helicobacter pylori infection and pancreatic cancer.
    Raderer M; Wrba F; Kornek G; Maca T; Koller DY; Weinlaender G; Hejna M; Scheithauer W
    Oncology; 1998; 55(1):16-9. PubMed ID: 9428370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk.
    Wang T; Cai H; Zheng W; Michel A; Pawlita M; Milne G; Xiang YB; Gao YT; Li HL; Rothman N; Lan Q; Shu XO; Epplein M
    Clin Infect Dis; 2017 May; 64(10):1380-1386. PubMed ID: 28402440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of seropositivity to Helicobacter species and biliary tract cancer in the ATBC study.
    Murphy G; Michel A; Taylor PR; Albanes D; Weinstein SJ; Virtamo J; Parisi D; Snyder K; Butt J; McGlynn KA; Koshiol J; Pawlita M; Lai GY; Abnet CC; Dawsey SM; Freedman ND
    Hepatology; 2014 Dec; 60(6):1963-71. PubMed ID: 24797247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.
    Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N
    Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China.
    Limburg P; Qiao Y; Mark S; Wang G; Perez-Perez G; Blaser M; Wu Y; Zou X; Dong Z; Taylor P; Dawsey S
    J Natl Cancer Inst; 2001 Feb; 93(3):226-33. PubMed ID: 11158192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men.
    Epplein M; Zheng W; Xiang YB; Peek RM; Li H; Correa P; Gao J; Michel A; Pawlita M; Cai Q; Shu XO
    Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2185-92. PubMed ID: 23035179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers.
    Limburg PJ; Stolzenberg-Solomon RZ; Colbert LH; Perez-Perez GI; Blaser MJ; Taylor PR; Virtamo J; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1095-9. PubMed ID: 12376513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.
    Murphy G; Freedman ND; Michel A; Fan JH; Taylor PR; Pawlita M; Qiao YL; Zhang H; Yu K; Abnet CC; Dawsey SM
    Int J Cancer; 2015 Oct; 137(8):1938-46. PubMed ID: 25845708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tooth loss is associated with increased risk of gastric non-cardia adenocarcinoma in a cohort of Finnish smokers.
    Abnet CC; Kamangar F; Dawsey SM; Stolzenberg-Solomon RZ; Albanes D; Pietinen P; Virtamo J; Taylor PR
    Scand J Gastroenterol; 2005 Jun; 40(6):681-7. PubMed ID: 16036528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori, Chlamydia pneumoniae and myocardial infarction.
    Fraser AG; Scragg RK; Cox B; Jackson RT
    Intern Med J; 2003 Jul; 33(7):267-72. PubMed ID: 12823670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori infection and risk of gastric cancer in Shanghai, China: updated results based upon a locally developed and validated assay and further follow-up of the cohort.
    Yuan JM; Yu MC; Xu WW; Cockburn M; Gao YT; Ross RK
    Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):621-4. PubMed ID: 10428200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Helicobacter pylori and Periampullary and Pancreatic Cancer: a Case-Control Study.
    Laya GB; Anandhi A; Gurushankari B; Mandal J; Kate V
    J Gastrointest Cancer; 2022 Dec; 53(4):902-907. PubMed ID: 34997478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter hepaticus and Helicobacter bilis in liver and biliary cancers from ATBC and PLCO.
    Murphy G; Freedman ND; Abnet CC; Albanes D; Cross AJ; Huang WY; Koshiol J; McGlynn K; Parisi D; Männistö S; Weinstein SJ; Waterboer T; Butt J
    Helicobacter; 2024; 29(1):e13053. PubMed ID: 38332674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between Helicobacter pylori and gastric carcinoma in the city of Malmö, Sweden. A prospective study.
    Simán JH; Forsgren A; Berglund G; Florén CH
    Scand J Gastroenterol; 1997 Dec; 32(12):1215-21. PubMed ID: 9438319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors.
    Lorenzo I; Fernández-de-Larrea N; Michel A; Romero B; Lope V; Bessa X; Moreno V; Martín V; Amiano P; Castilla J; Tardón A; Dierssen-Sotos T; Peiró R; Díaz-Santos M; Navarro C; Jiménez-Moleón JJ; Butt J; Barricarte A; Ruiz I; Molina-de-la-Torre AJ; Casabonne D; Pérez-Gómez B; Kogevinas M; Del Campo R; de Sanjosé S; Pollán M; Waterboer T; Aragonés N
    Eur J Cancer Prev; 2019 Jul; 28(4):294-303. PubMed ID: 30489354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicobacter pylori infection is associated with a decreased risk of developing oesophageal neoplasms.
    Henrik Simán J; Forsgren A; Berglund G; Florén CH
    Helicobacter; 2001 Dec; 6(4):310-6. PubMed ID: 11843963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between systemic lupus erythematosus and Helicobacter pylori seronegativity.
    Sawalha AH; Schmid WR; Binder SR; Bacino DK; Harley JB
    J Rheumatol; 2004 Aug; 31(8):1546-50. PubMed ID: 15290733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study.
    Palli D; Masala G; Del Giudice G; Plebani M; Basso D; Berti D; Numans ME; Ceroti M; Peeters PH; Bueno de Mesquita HB; Buchner FL; Clavel-Chapelon F; Boutron-Ruault MC; Krogh V; Saieva C; Vineis P; Panico S; Tumino R; Nyrén O; Simán H; Berglund G; Hallmans G; Sanchez MJ; Larrãnaga N; Barricarte A; Navarro C; Quiros JR; Key T; Allen N; Bingham S; Khaw KT; Boeing H; Weikert C; Linseisen J; Nagel G; Overvad K; Thomsen RW; Tjonneland A; Olsen A; Trichoupoulou A; Trichopoulos D; Arvaniti A; Pera G; Kaaks R; Jenab M; Ferrari P; Nesi G; Carneiro F; Riboli E; Gonzalez CA
    Int J Cancer; 2007 Feb; 120(4):859-67. PubMed ID: 17131317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies.
    Jacobs EJ; Newton CC; Silverman DT; Nogueira LM; Albanes D; Männistö S; Pollak M; Stolzenberg-Solomon RZ
    Cancer Causes Control; 2014 Sep; 25(9):1083-91. PubMed ID: 24913781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tooth loss, pancreatic cancer, and Helicobacter pylori.
    Stolzenberg-Solomon RZ; Dodd KW; Blaser MJ; Virtamo J; Taylor PR; Albanes D
    Am J Clin Nutr; 2003 Jul; 78(1):176-81. PubMed ID: 12816788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.